Plasma GFAP, a marker of reactive astrocytes, is considered a plasma biomarker linking amyloid pathology to early tau pathology, as Aβ is associated with p-tau only in individuals with higher GFAP levels [324]. Here, MAPT is linked to amyloidosis.